Previous studies have revealed that the increasing level of MLCK and MLC phosphorylation (p-MLC) was an important pathway leading to intestinal TJ barrier malfunction in the in vivo and in vitro models of IBD (Figure 1) (35, 49). Here, MYLK is linked to inflammatory bowel disease.